Phase 1 Opioid-use Disorder Clinical Trials
12 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–12 of 12 trials
Recruiting
Phase 1
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
Pancreatic SurgeryChronic PainChronic Pancreatitis+7 more
Indiana University24 enrolled5 locationsNCT05603702
Recruiting
Phase 1
OMAR Opioid Use Disorder
Healthy ControlOpioid-use Disorder
Yale University30 enrolled1 locationNCT05683184
Recruiting
Phase 1Phase 2
Clinical Trials of Multivalent Opioid Vaccine Components
Opioid-use Disorder
New York State Psychiatric Institute45 enrolled2 locationsNCT04458545
Recruiting
Phase 1
A Study to Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking Buprenorphine
Opioid-use Disorder
Boehringer Ingelheim60 enrolled5 locationsNCT06628622
Recruiting
Phase 1Phase 2
A Bundled Intervention
Opioid-use DisorderOpioid Overdose
University of Alabama at Birmingham190 enrolled1 locationNCT06593093
Recruiting
Phase 1
Cannabis and Opioid Use Disorder
Opioid-use Disorder
University of Kentucky15 enrolled1 locationNCT05729932
Recruiting
Phase 1
Adjunctive Effects of Psilocybin and a Formulation of Buprenorphine
Opioid-use Disorder
University of Wisconsin, Madison10 enrolled1 locationNCT04161066
Recruiting
Phase 1
Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings
Opioid-use Disorder
Boulder Care250 enrolled1 locationNCT07169409
Recruiting
Phase 1
Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in Opioid Use Disorder
MindfulnessOpioid-use DisorderGuanfacine
Rutgers, The State University of New Jersey224 enrolled1 locationNCT06642181
Recruiting
Phase 1
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
Opioid-use Disorder
Yale University12 enrolled1 locationNCT06160284
Recruiting
Phase 1
Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder
Opioid-use Disorder
Proniras Corporation40 enrolled1 locationNCT06538558
Recruiting
Phase 1Phase 2
Ketamine Assisted Psychotherapy for Opioid Use Disorder
Opioid-use Disorder
University of Utah60 enrolled1 locationNCT04892251